Free Trial
NASDAQ:PTPI

Petros Pharmaceuticals (PTPI) Stock Price, News & Analysis

Petros Pharmaceuticals logo
$0.03 0.00 (0.00%)
As of 03:41 PM Eastern

About Petros Pharmaceuticals Stock (NASDAQ:PTPI)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.16
52-Week Range
$0.02
$16.25
Volume
273,354 shs
Average Volume
3.18 million shs
Market Capitalization
$897.41 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PTPI Stock News Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Petros Pharmaceuticals, Inc. (PTPI) - Yahoo Finance
See More Headlines

PTPI Stock Analysis - Frequently Asked Questions

Petros Pharmaceuticals' stock was trading at $9.8475 at the start of the year. Since then, PTPI shares have decreased by 99.7% and is now trading at $0.0288.

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($8.46) earnings per share for the quarter.

Petros Pharmaceuticals's stock reverse split on Thursday, May 1st 2025.The 1-25 reverse split was announced on Tuesday, April 29th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of PTPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Petros Pharmaceuticals investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), Abbott Laboratories (ABT), Cricut (CRCT) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/15/2025
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PTPI
CIK
1815903
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($60.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.16 million
Net Margins
N/A
Pretax Margin
-117.50%
Return on Equity
-78.22%
Return on Assets
-23.50%

Debt

Debt-to-Equity Ratio
1.58
Current Ratio
0.85
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$5.11 million
Price / Sales
0.18
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
31,160,000
Free Float
9,932,000
Market Cap
$897.41 thousand
Optionable
Not Optionable
Beta
1.56
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:PTPI) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners